Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective, Randomized, Open, Multicentre Study About the Effect of an Empirical Antibiotic Monotherapy With Meropenem (Meronem) Versus a Combination Therapy With Moxifloxacin (Avalox) on Organ Dysfunction in Patients With Severe Sepsis and Septic Shock.

Next Previous
Trial Profile

Prospective, Randomized, Open, Multicentre Study About the Effect of an Empirical Antibiotic Monotherapy With Meropenem (Meronem) Versus a Combination Therapy With Moxifloxacin (Avalox) on Organ Dysfunction in Patients With Severe Sepsis and Septic Shock.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2014

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Meropenem (Primary) ; Moxifloxacin (Primary)
  • Indications Sepsis; Septic shock
  • Focus Therapeutic Use
  • Acronyms MaxSep

    • Most Recent Events

    • 13 Jun 2012 Results published in JAMA: the Journal of the American Medical Association.
    • 13 Jun 2012 Primary endpoint 'Assessment-scale-scores' has not been met.
    • 02 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top